Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Insulinoma 4Hypoglycemia 4Congenital Hyperinsulinism 4Neuroendocrine Tumors 3Neuroblastoma 3Hyperinsulinism 3Pheochromocytoma 2Parkinson Disease 2Carcinoid Tumor 2Thyroid cancer, medullary 1Parathyroid Neoplasms 1Paraganglioma 1Multiple Endocrine Neoplasia 1Lewy Body Disease 1Infant, Newborn, Diseases 1Hyperparathyroidism 1Hypercalcemia 1Glucose Metabolism Disorders 1Endocrine System Diseases 1Brain Neoplasms 1Beckwith-Wiedemann Syndrome 1

Interventions

fluorodopa F 18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glucose Metabolism Disorders × fluorodopa F 18 × Endocrine × Clear all
NCT05088798 2025-12-19

18FDOPA HI

Washington University School of Medicine

Phase 2 Recruiting
100 enrolled
Endocrine

Hyperinsulinism, Hypoglycemia, Infant, Newborn, Diseases, Insulinoma, Glucose Metabolism Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡